Metabolic reprogramming in diffuse intrinsic pontine gliomas (DIPG): dual inhibition of mitochondrial oxidative phosphorylation and lactate metabolism to enhance anti-tumor and radiosensitizing effects in DIPG cells.

Saved in:
Bibliographic Details
Title: Metabolic reprogramming in diffuse intrinsic pontine gliomas (DIPG): dual inhibition of mitochondrial oxidative phosphorylation and lactate metabolism to enhance anti-tumor and radiosensitizing effects in DIPG cells.
Authors: Shen H; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia.; Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia., Huynh QS; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia., Mudassar F; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia., Chang C; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia., Gloss B; Westmead Research Hub Core Facilities, Westmead Institute for Medical Research, Westmead, NSW, Australia., Ing P; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia., Ma S; Basic Medicine Research and Innovation Center for Novel Target and Therapeutic Intervention, The Ministry of Education, College of Pharmacy, Chongqing Medical University, Chongqing, China., Gee H; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia.; Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia.; Western Sydney Radiation Oncology Network, Sydney, NSW, Australia., Hau E; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia. Eric.Hau@health.nsw.gov.au.; Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia. Eric.Hau@health.nsw.gov.au.; Western Sydney Radiation Oncology Network, Sydney, NSW, Australia. Eric.Hau@health.nsw.gov.au., Cook KM; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia. kristina.cook@sydney.edu.au.; Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia. kristina.cook@sydney.edu.au.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia. kristina.cook@sydney.edu.au.
Source: Cancer & metabolism [Cancer Metab] 2025 Oct 29; Vol. 13 (1), pp. 43. Date of Electronic Publication: 2025 Oct 29.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101607582 Publication Model: Electronic Cited Medium: Print ISSN: 2049-3002 (Print) Linking ISSN: 20493002 NLM ISO Abbreviation: Cancer Metab Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41163069
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Metabolic reprogramming in diffuse intrinsic pontine gliomas (DIPG): dual inhibition of mitochondrial oxidative phosphorylation and lactate metabolism to enhance anti-tumor and radiosensitizing effects in DIPG cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shen+H%22">Shen H</searchLink>; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia.; Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Huynh+QS%22">Huynh QS</searchLink>; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia.<br /><searchLink fieldCode="AU" term="%22Mudassar+F%22">Mudassar F</searchLink>; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia.<br /><searchLink fieldCode="AU" term="%22Chang+C%22">Chang C</searchLink>; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia.<br /><searchLink fieldCode="AU" term="%22Gloss+B%22">Gloss B</searchLink>; Westmead Research Hub Core Facilities, Westmead Institute for Medical Research, Westmead, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Ing+P%22">Ing P</searchLink>; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia.<br /><searchLink fieldCode="AU" term="%22Ma+S%22">Ma S</searchLink>; Basic Medicine Research and Innovation Center for Novel Target and Therapeutic Intervention, The Ministry of Education, College of Pharmacy, Chongqing Medical University, Chongqing, China.<br /><searchLink fieldCode="AU" term="%22Gee+H%22">Gee H</searchLink>; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia.; Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia.; Western Sydney Radiation Oncology Network, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Hau+E%22">Hau E</searchLink>; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia. Eric.Hau@health.nsw.gov.au.; Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia. Eric.Hau@health.nsw.gov.au.; Western Sydney Radiation Oncology Network, Sydney, NSW, Australia. Eric.Hau@health.nsw.gov.au.<br /><searchLink fieldCode="AU" term="%22Cook+KM%22">Cook KM</searchLink>; Translational Radiation Biology and Oncology Laboratory, Centre for Cancer Research, Westmead Institute for Medical Research, NSW, Westmead, Australia. kristina.cook@sydney.edu.au.; Faculty of Medicine and Health, School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia. kristina.cook@sydney.edu.au.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia. kristina.cook@sydney.edu.au.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101607582%22">Cancer & metabolism</searchLink> [Cancer Metab] 2025 Oct 29; Vol. 13 (1), pp. 43. <i>Date of Electronic Publication: </i>2025 Oct 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101607582 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2049-3002 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220493002%22">20493002 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Metab <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41163069
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s40170-025-00411-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 43
    Titles:
      – TitleFull: Metabolic reprogramming in diffuse intrinsic pontine gliomas (DIPG): dual inhibition of mitochondrial oxidative phosphorylation and lactate metabolism to enhance anti-tumor and radiosensitizing effects in DIPG cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shen H
      – PersonEntity:
          Name:
            NameFull: Huynh QS
      – PersonEntity:
          Name:
            NameFull: Mudassar F
      – PersonEntity:
          Name:
            NameFull: Chang C
      – PersonEntity:
          Name:
            NameFull: Gloss B
      – PersonEntity:
          Name:
            NameFull: Ing P
      – PersonEntity:
          Name:
            NameFull: Ma S
      – PersonEntity:
          Name:
            NameFull: Gee H
      – PersonEntity:
          Name:
            NameFull: Hau E
      – PersonEntity:
          Name:
            NameFull: Cook KM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 10
              Text: 2025 Oct 29
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2049-3002
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer & metabolism
              Type: main
ResultId 1